Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Inhibition of dendritic cell maturation by the tumor microenvironment correlates with the survival of colorectal cancer patients following bevacizumab treatment.
Michielsen AJ, Noonan S, Martin P, Tosetto M, Marry J, Biniecka M, Maguire AA, Hyland JM, Sheahan KD, O'Donoghue DP, Mulcahy HE, Fennelly D, Ryan EJ, O'Sullivan JN. Michielsen AJ, et al. Among authors: fennelly d. Mol Cancer Ther. 2012 Aug;11(8):1829-37. doi: 10.1158/1535-7163.MCT-12-0162. Epub 2012 Jun 6. Mol Cancer Ther. 2012. PMID: 22675042
Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment.
Noonan SA, Morrissey ME, Martin P, Biniecka M, Ó'Meachair S, Maguire A, Tosetto M, Nolan B, Hyland J, Sheahan K, O'Donoghue D, Mulcahy H, Fennelly D, O'Sullivan J. Noonan SA, et al. Among authors: fennelly d. Oncotarget. 2018 Jan 19;9(12):10536-10548. doi: 10.18632/oncotarget.24276. eCollection 2018 Feb 13. Oncotarget. 2018. PMID: 29535825 Free PMC article.
KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
Caiazza F, Oficjalska K, Tosetto M, Phelan JJ, Noonan S, Martin P, Killick K, Breen L, O'Neill F, Nolan B, Furney S, Power R, Fennelly D, Craik CS, O'Sullivan J, Sheahan K, Doherty GA, Ryan EJ. Caiazza F, et al. Among authors: fennelly d. Am J Pathol. 2019 Oct;189(10):1916-1932. doi: 10.1016/j.ajpath.2019.07.004. Epub 2019 Aug 9. Am J Pathol. 2019. PMID: 31404541 Free PMC article.
Characterising the prognostic potential of HLA-DR during colorectal cancer development.
Dunne MR, Phelan JJ, Michielsen AJ, Maguire AA, Dunne C, Martin P, Noonan S, Tosetto M, Geraghty R, Fennelly D, Sheahan K, Ryan EJ, O'Sullivan J. Dunne MR, et al. Among authors: fennelly d. Cancer Immunol Immunother. 2020 Aug;69(8):1577-1588. doi: 10.1007/s00262-020-02571-2. Epub 2020 Apr 18. Cancer Immunol Immunother. 2020. PMID: 32306077 Free PMC article.
Nuclear oxidative damage correlates with poor survival in colorectal cancer.
Sheridan J, Wang LM, Tosetto M, Sheahan K, Hyland J, Fennelly D, O'Donoghue D, Mulcahy H, O'Sullivan J. Sheridan J, et al. Among authors: fennelly d. Br J Cancer. 2009 Jan 27;100(2):381-8. doi: 10.1038/sj.bjc.6604821. Epub 2008 Dec 9. Br J Cancer. 2009. PMID: 19066606 Free PMC article. Clinical Trial.
79 results